<style>
.trajectory-box strong {
  color: #1a1a1a !important;
}
.trajectory-box h3 {
  color: #1a1a1a !important;
}
</style>

# lm-planner/llama-3.1-405b-instruct/BetterBodies__Reinforcement_Learning_guided_Diffusion_for_Antibody_Sequence_Design

<div style="background: linear-gradient(135deg, #e3f2fd 0%, #bbdefb 100%); border-left: 5px solid #2196f3; padding: 20px; margin: 20px 0; border-radius: 8px; box-shadow: 0 2px 8px rgba(0,0,0,0.1); color: #1a1a1a;" class="trajectory-box">
<h2 style="color: #1976d2; margin-top: 0; margin-bottom: 15px; font-size: 1.3em;">🧠 Reasoning Trace</h2>

The paper "BetterBodies: Reinforcement Learning guided Diffusion for Antibody Sequence Design" presents a novel method for antibody sequence design using reinforcement learning and diffusion models. The method, called BetterBodies, uses a variational autoencoder (VAE) to encode amino acids into a continuous latent space, and a diffusion model to generate novel sequences. The diffusion model is guided by a learned Q-function, which predicts the binding affinity of the generated sequences.

The paper presents several ablation studies to evaluate the effectiveness of the proposed method. However, there are some missing ablation studies that could provide further insights into the method's performance.

One potential missing ablation study is the evaluation of the impact of the VAE's latent space dimensionality on the method's performance. The paper uses a 2D latent space, but it would be interesting to see how the method performs with different latent space dimensionalities.

Another potential missing ablation study is the evaluation of the impact of the Q-function's architecture on the method's performance. The paper uses a clipped double Q-learning architecture, but it would be interesting to see how the method performs with different Q-function architectures.

Additionally, it would be interesting to see an ablation study on the impact of the diffusion model's noise schedule on the method's performance. The paper uses a fixed noise schedule, but it would be interesting to see how the method performs with different noise schedules.

Overall, the paper presents a promising method for antibody sequence design, and further ablation studies could provide valuable insights into the method's performance and limitations.
</div>

<div style="background: linear-gradient(135deg, #e8f5e8 0%, #c8e6c9 100%); border-left: 5px solid #4caf50; padding: 20px; margin: 20px 0; border-radius: 8px; box-shadow: 0 2px 8px rgba(0,0,0,0.1); color: #1a1a1a;" class="trajectory-box">
<h2 style="color: #2e7d32; margin-top: 0; margin-bottom: 15px; font-size: 1.3em;">📋 Ablation Plan</h2>

### Ablation A
- **Ablated Part**: VAE latent space dimensionality
- **Action**: REPLACE
- **Replacement**: 
  - 2
  - 5
  - 10
- **Metrics**: binding affinity, diversity, novelty

### Ablation B
- **Ablated Part**: Q-function architecture
- **Action**: REPLACE
- **Replacement**: 
  - clipped double Q-learning
  - deep Q-networks
  - policy gradient methods
- **Metrics**: binding affinity, diversity, novelty

### Ablation C
- **Ablated Part**: diffusion model's noise schedule
- **Action**: REPLACE
- **Replacement**: 
  - fixed noise schedule
  - learned noise schedule
  - scheduled noise schedule
- **Metrics**: binding affinity, diversity, novelty

</div>